CCO Official Conference Coverage: Clinical Impact of New HIV Data From AIDS 2022

Dr Sharon R. Lewin, incoming President of the International AIDS Society, provides an overview of the most clinically exciting papers to be presented at the upcoming conference.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: July 13, 2022

Read my take on the most practice-changing clinical presentations from the recent AIDS 2022 conference in Montreal.

Daniel R. Kuritzkes, MD Released: August 23, 2022

Read expert faculty members’ summaries of key HIV studies from AIDS 2022, including results from studies of prevention strategies, oral therapies, long-acting therapies, cure, and comorbidities.

Chloe Orkin, MBChB, FRCP, MD Babafemi Taiwo, MBBS David A. Wohl, MD Released: August 17, 2022

Listen to expert insights from Chloe Orkin, MBChB, FRCP, MD, on some of the most clinically relevant new data presented at AIDS 2022, including prevention strategies, oral and long-acting therapies, cure, and COVID-19 in people with HIV.

Chloe Orkin, MBChB, FRCP, MD Released: October 4, 2022

Hear from expert faculty as they present their insights on some of the most clinically relevant new data presented at AIDS 2022, including prevention strategies, oral therapies, long-acting therapies, cure, and COVID-19 in PWH.

David A. Wohl, MD Released: August 19, 2022

Hear from expert faculty as they present their insights on some of the most clinically relevant new data presented at AIDS 2022, including prevention strategies, oral therapies, long-acting therapies, cure, and COVID-19 in PWH.

Chloe Orkin, MBChB, FRCP, MD Released: September 20, 2022